Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$359,029
+$21,496 QoQ
Shares Held
2,794
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,988
of 3,769 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TigerOak Management, L.L.C. holds $6,289,271 across 7 Drug Manufacturers - General names. MRK ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,577 | $3,448,150 | |
| 2 | ABBV |
AbbVie Inc.
|
4,032 | $1,014,612 | |
| 3 | LLY |
ELI LILLY & Co
|
478 | $573,327 | |
| 4 | NVS |
Novartis AG
|
3,041 | $476,585 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
2,794 | $359,029 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,627 | $208,987 | |
| 7 | AMGN |
Amgen Inc
|
576 | $208,581 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,029 | 2,794 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $337,533 | 2,806 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $295,359 | 2,806 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $235,507 | 2,806 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $233,126 | 2,945 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $250,340 | 2,789 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $342,708 | 3,445 | Shares | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||